本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Biodesix, Inc.

0.4952
+0.00521.06%
盘后0.49520.00000.00%16:08 EDT
成交量:49.94万
成交额:24.22万
市值:7,228.85万
市盈率:-1.50
高:0.5199
开:0.5130
低:0.4500
收:0.4900
数据加载中...
2024/02/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/07

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/12/20

重要事件披露

Form 8-K - Current report
2023/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/08

重要事件披露

Form 8-K - Current report
2023/08/11

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/08

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/08

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/07

重要事件披露

Form 8-K - Current report
2023/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/27

重要事件披露

Form 8-K - Current report
2023/07/03

SEC问询函

Form CORRESP - Correspondence
2023/06/07

重要事件披露

Form 8-K - Current report
2023/05/25

重要事件披露

Form 8-K - Current report
2023/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]